1
Participants
Start Date
October 23, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Pfizer-BioNTech COVID-19 mRNA vaccine
Pfizer-BioNTech COVID-19 Vaccine, is FDA licensed or authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older.
Pfizer, New York
Lead Sponsor
Pfizer
INDUSTRY